M&R Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.56K | Hold |
136
| – | – | ﹤0.01% | 453 |
|
|
2024
Q2 | $5.24K | Hold |
136
| – | – | ﹤0.01% | 438 |
|
|
2024
Q1 | $5.83K | Hold |
136
| – | – | ﹤0.01% | 433 |
|
|
2023
Q4 | $5.04K | Hold |
136
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $4.93K | Hold |
136
| – | – | ﹤0.01% | 468 |
|
|
2023
Q2 | $4.85K | Hold |
136
| – | – | ﹤0.01% | 468 |
|
|
2023
Q1 | $4.84K | Hold |
136
| – | – | ﹤0.01% | 449 |
|
|
2022
Q4 | $4.78K | Hold |
136
| – | – | ﹤0.01% | 421 |
|
|
2022
Q3 | $4K | Hold |
136
| – | – | ﹤0.01% | 387 |
|
|
2022
Q2 | $7K | Hold |
136
| – | – | ﹤0.01% | 352 |
|
|
2022
Q1 | $7K | Hold |
136
| – | – | ﹤0.01% | 359 |
|
|
2021
Q4 | $7K | Hold |
136
| – | – | ﹤0.01% | 347 |
|
|
2021
Q3 | $6K | Hold |
136
| – | – | ﹤0.01% | 361 |
|
|
2021
Q2 | $6K | Hold |
136
| – | – | ﹤0.01% | 362 |
|
|
2021
Q1 | $6K | Sell |
136
-269
| -66% | -$12.2K | ﹤0.01% | 356 |
|
|
2020
Q4 | $18K | Sell |
405
-200
| -33% | -$9.19K | ﹤0.01% | 313 |
|
|
2020
Q3 | $28K | Hold |
605
| – | – | 0.01% | 286 |
|
|
2020
Q2 | $30K | Hold |
605
| – | – | 0.01% | 281 |
|
|
2020
Q1 | $28K | Hold |
605
| – | – | 0.01% | 280 |
|
|
2019
Q4 | $35K | Hold |
605
| – | – | 0.01% | 289 |
|
|
2019
Q3 | $32K | Hold |
605
| – | – | 0.01% | 313 |
|
|
2019
Q2 | $30K | Hold |
605
| – | – | 0.01% | 323 |
|
|
2019
Q1 | $30K | Sell |
605
-200
| -25% | -$9.99K | 0.01% | 326 |
|
|
2018
Q4 | $38K | Hold |
805
| – | – | 0.01% | 287 |
|
|
2018
Q3 | $40K | Hold |
805
| – | – | 0.01% | 308 |
|
|
2018
Q2 | $40K | Hold |
805
| – | – | 0.01% | 303 |
|
|
2018
Q1 | $39K | Hold |
805
| – | – | 0.01% | 324 |
|
|
2017
Q4 | $35K | Sell |
805
-1,280
| -61% | -$59.1K | 0.01% | 332 |
|
|
2017
Q3 | $105K | Hold |
2,085
| – | – | 0.03% | 228 |
|
|
2017
Q2 | $101K | Sell |
2,085
-400
| -16% | -$21.3K | 0.03% | 235 |
|
|
2017
Q1 | $130K | Hold |
2,485
| – | – | 0.03% | 212 |
|
|
2016
Q4 | $119K | Buy |
2,485
+456
| +22% | +$22.5K | 0.03% | 207 |
|
|
2016
Q3 | $109K | Hold |
2,029
| – | – | 0.03% | 205 |
|
|
2016
Q2 | $109K | Buy |
+2,029
| New | +$107K | 0.03% | 205 |
|
Other funds holding GSK
JEST
M&R Capital Management's GSK Position: Q3 2024 in Review
M&R Capital Management held its GSK (GSK) position steady in Q3 2024 at 136 shares worth $5.56K. The position accounts for ﹤0.01% of the portfolio, ranked #453.
M&R Capital Management first reported a position in GSK in Q2 2016 and has held it in 34 quarters since. The position peaked at $130K in Q1 2017. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.
- M&R Capital Management held 136 shares of GSK worth $5.56K as of Q3 2024.
- M&R Capital Management left its GSK share count unchanged in Q3 2024.
- GSK made up ﹤0.01% of M&R Capital Management's portfolio in Q3 2024, its #453 holding.
- M&R Capital Management first reported a position in GSK in Q2 2016 and has held it in 34 quarters since.
- M&R Capital Management's GSK position peaked at $130K in Q1 2017.
- 900 funds tracked by Wall St. Rank held GSK as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.